Search research articles
Contact Us
Filters
Showing results (601-610 of 633) with videos related to
Page
of 64
Sort By:
Recent Patents on Anti-Cancer Drug Discovery
|
January 13, 2022
Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer
Kun Liu, Yu Chen, Xiao-Bao Shi, et al.
Oncotarget
|
July 2, 2014
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
De-Shen Wang, Atish Patel, Suneet Shukla, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 17, 2022
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
Kun Pang, Zhen-Duo Shi, Liu-Ya Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 11, 2025
Branched-Chain α Keto-Acid Dehydrogenase Kinase-Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance
Qin Tian, Jinxiang Wang, Qiji Li, et al.
Molecular Cancer
|
September 15, 2021
MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Haichang Li, Pei-Hui Lin, Pranav Gupta, et al.
Molecular Pharmaceutics
|
May 29, 2012
Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202
Chao Cheng, Zhen-guo Liu, Hui Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
January 13, 2006
[Expression and significance of C-kit and platelet-derived growth factor receptor-beta (PDGFRbeta) in esophageal carcinoma]
Xu Zhang, Tie-Hua Rong, Yu Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
February 13, 2004
[Shrinkage of resected specimens of esophageal carcinoma]
Guo-Wei Ma, Tie-Hua Rong, Hao Long, et al.
Acta Pharmaceutica Sinica. B
|
August 15, 2022
Preclinical studies of the triazolo[1,5-<i>a</i>]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor
Sai-Qi Wang, Qiu-Xu Teng, Shuai Wang, et al.
Page
of 64
Search research articles
Search
Showing results (601-610 of 633) with videos related to
Sort By:
Page
of 64
Recent Patents on Anti-Cancer Drug Discovery
|
January 13, 2022
Inhibiting the Activity of ABCG2 by KU55933 in Colorectal Cancer
Kun Liu, Yu Chen, Xiao-Bao Shi, et al.
Oncotarget
|
July 2, 2014
Icotinib antagonizes ABCG2-mediated multidrug resistance, but not the pemetrexed resistance mediated by thymidylate synthase and ABCG2
De-Shen Wang, Atish Patel, Suneet Shukla, et al.
Molecular Pharmaceutics
|
August 5, 2011
Blockade of Her2/neu binding to Hsp90 by emodin azide methyl anthraquinone derivative induces proteasomal degradation of Her2/neu
Yan-yan Yan, Li-sheng Zheng, Xu Zhang, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
|
December 17, 2022
Research progress of therapeutic effects and drug resistance of immunotherapy based on PD-1/PD-L1 blockade
Kun Pang, Zhen-Duo Shi, Liu-Ya Wei, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
|
August 11, 2025
Branched-Chain α Keto-Acid Dehydrogenase Kinase-Mediated AKT Phosphorylation Promotes RCC Tumorigenesis and Drug Resistance
Qin Tian, Jinxiang Wang, Qiji Li, et al.
Molecular Cancer
|
September 15, 2021
MG53 suppresses tumor progression and stress granule formation by modulating G3BP2 activity in non-small cell lung cancer
Haichang Li, Pei-Hui Lin, Pranav Gupta, et al.
Molecular Pharmaceutics
|
May 29, 2012
Enhancing chemosensitivity in ABCB1- and ABCG2-overexpressing cells and cancer stem-like cells by an Aurora kinase inhibitor CCT129202
Chao Cheng, Zhen-guo Liu, Hui Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
January 13, 2006
[Expression and significance of C-kit and platelet-derived growth factor receptor-beta (PDGFRbeta) in esophageal carcinoma]
Xu Zhang, Tie-Hua Rong, Yu Zhang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer
|
February 13, 2004
[Shrinkage of resected specimens of esophageal carcinoma]
Guo-Wei Ma, Tie-Hua Rong, Hao Long, et al.
Acta Pharmaceutica Sinica. B
|
August 15, 2022
Preclinical studies of the triazolo[1,5-<i>a</i>]pyrimidine derivative WS-716 as a highly potent, specific and orally active P-glycoprotein (P-gp) inhibitor
Sai-Qi Wang, Qiu-Xu Teng, Shuai Wang, et al.
Page
of 64